Literature DB >> 14963169

Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11.

Stephen T Oh1, Michelle S Longworth, Laimonis A Laimins.   

Abstract

Many important functions have been attributed to the high-risk human papillomavirus (HPV) E6 and E7 proteins, including binding and degradation of p53 as well as interacting with Rb proteins. In contrast, the physiological roles of the low-risk E6 and E7 proteins remain unclear. Previous studies demonstrated that the high-risk E6 and E7 proteins also play roles in the productive life cycle by facilitating the maintenance of viral episomes (J. T. Thomas, W. G. Hubert, M. N. Ruesch, and L. A. Laimins, Proc. Natl. Acad. Sci. USA 96:8449-8454, 1999). In order to determine whether low-risk E6 or E7 is similarly necessary for the stable maintenance of episomes, HPV type 11 (HPV-11) genomes that contained translation termination mutations in E6 or E7 were constructed. Upon transfection into normal human keratinocytes, genomes in which E6 function was abolished were unable to be maintained episomally. Transfection of genomes containing substitution mutations in amino acids conserved in high- and low-risk HPV types suggested that multiple protein domains are involved in this process. Examination of cells transfected with HPV-11 genomes in which E7 function was inhibited were found to exhibit a more complex phenotype. At the second passage following transfection, mutant genomes were maintained as episomes but at significantly reduced levels than in cells transfected with the wild-type HPV-11 genome. Upon further passage in culture, however, the episomal forms of these E7 mutant genomes quickly disappeared. These findings identify important new functions for the low-risk E6 and E7 proteins in the episomal maintenance of low-risk HPV-11 genomes and suggest that they may act in a manner similar to that observed for the high-risk proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14963169      PMCID: PMC369251          DOI: 10.1128/jvi.78.5.2620-2626.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins.

Authors:  B A Glaunsinger; S S Lee; M Thomas; L Banks; R Javier
Journal:  Oncogene       Date:  2000-11-02       Impact factor: 9.867

2.  Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins.

Authors:  S S Lee; B Glaunsinger; F Mantovani; L Banks; R T Javier
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

Review 3.  Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.

Authors:  H zur Hausen
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

4.  HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase.

Authors:  D Pim; M Thomas; R Javier; D Gardiol; L Banks
Journal:  Oncogene       Date:  2000-02-10       Impact factor: 9.867

5.  The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle.

Authors:  E R Flores; B L Allen-Hoffmann; D Lee; P F Lambert
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 6.  The biology of human papillomaviruses: from warts to cancer.

Authors:  L A Laimins
Journal:  Infect Agents Dis       Date:  1993-04

7.  Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53.

Authors:  M Scheffner; J M Huibregtse; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

8.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.

Authors:  M Scheffner; J M Huibregtse; R D Vierstra; P M Howley
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

Review 9.  Human papillomaviruses.

Authors:  H zur Hausen; E M de Villiers
Journal:  Annu Rev Microbiol       Date:  1994       Impact factor: 15.500

10.  Human papillomavirus type 31b late gene expression is regulated through protein kinase C-mediated changes in RNA processing.

Authors:  M Hummel; H B Lim; L A Laimins
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  34 in total

Review 1.  Mechanisms of human papillomavirus-induced oncogenesis.

Authors:  Karl Münger; Amy Baldwin; Kirsten M Edwards; Hiroyuki Hayakawa; Christine L Nguyen; Michael Owens; Miranda Grace; Kyungwon Huh
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 2.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

3.  The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.

Authors:  Benyue Zhang; Wei Chen; Ann Roman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-28       Impact factor: 11.205

Review 4.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

5.  Low- and high-risk human papillomavirus E7 proteins regulate p130 differently.

Authors:  Lisa Barrow-Laing; Wei Chen; Ann Roman
Journal:  Virology       Date:  2010-02-26       Impact factor: 3.616

6.  Human Papillomavirus 11 Early Protein E6 Activates Autophagy by Repressing AKT/mTOR and Erk/mTOR.

Authors:  Boya Zhang; Yinjing Song; Siyuan Sun; Rui Han; Chunting Hua; Stijn van der Veen; Hao Cheng
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

7.  Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein.

Authors:  Nicole Brimer; Charles Lyons; Scott B Vande Pol
Journal:  Virology       Date:  2006-10-04       Impact factor: 3.616

8.  Genomic Instability Induced By Human Papillomavirus Oncogenes.

Authors:  Jason J Chen
Journal:  N Am J Med Sci (Boston)       Date:  2010-04

9.  In inverted papillomas HPV more likely represents incidental colonization than an etiological factor.

Authors:  Klemen Jenko; Boštjan Kocjan; Nina Zidar; Mario Poljak; Primož Strojan; Miha Zargi; Olga Blatnik; Nina Gale
Journal:  Virchows Arch       Date:  2011-09-09       Impact factor: 4.064

10.  Nonconserved lysine residues attenuate the biological function of the low-risk human papillomavirus E7 protein.

Authors:  Nicholas J Genovese; Thomas R Broker; Louise T Chow
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.